Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Tianjin Medical University General Hospital

2 clinical trials · 2 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Tianjin Medical University General Hospital

RECRUITINGPhase 1 / Phase 2NCT06911710

The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors

This study is an open, single-arm, prospective, Phase I/II clinical study using "3+3" dose escalation and dose expansion to investigate the safety, maximum tolerated dose, in vivo...

Sponsor: Tianjin Medical University General HospitalEnrolling: 901 location
Lymphoma, B-cell, Aggressive Non-Hodgkin (B-NHL)AML (Acute Myelogenous Leukemia)Myeloma Multiple+3
RECRUITINGPhase 1 / Phase 2NCT07022197

Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases

This study is a phase Ib/IIa dose-escalation study designed to evaluate the safety, tolerability, and preliminary efficacy of autologous T cells expressing chimeric antigen...

Sponsor: Tianjin Medical University General HospitalEnrolling: 271 location
Chronic Inflammatory Demyelinating PolyradiculoneuropathyNMO Spectrum DisorderMyasthenia Gravis+1